Zuogui Pills alleviate iron overload-induced osteoporosis by attenuating ROS-mediated osteoblast apoptosis via the PI3K-AKT pathway and mitigating mitochondrial damage
Journal of Ethnopharmacology · 2025-03 · 344 · 119455
DOI: 10.1016/j.jep.2025.119455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025-03. Verfasst von Yuewei Lin und 18 weiteren Autor:innen. Beteiligte Einrichtung: First School of Clinical Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, PR China; The Laborator…. Hauptthemen laut MEDLINE: Osteoblasts, Osteoporosis, Drugs, Chinese Herbal, Iron Overload. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Guangdong Provincial Natural Science Foundation, Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Zuogui Pill (ZGP) is a classic herbal formula in Traditional Chinese Medicine, primarily used to tonify the kidney and replenish essence, and is widely applied in treating various kidney deficiency-related conditions. Over time, ZGP has demonstrated significant efficacy in addressing symptoms such as fatigue, weakness, and soreness of the lower back and knees, which are often caused by kidney deficiency. According to Traditional Chinese Medicine theory, the kidneys govern the bones, meaning that sufficient kidney essence is closely related to bone strength. By nourishing the kidneys and replenishing essence, ZGP helps to increase bone density and improve bone microstructure, making it an important therapeutic option for osteoporosis. AIM OF THE STUDY: To investigate the protective effects of ZGP in iron overload-induced osteoporosis and elucidate its molecular mechanisms through the activation of the Phosphoinositide 3-Kinase (PI3K)/Protein Kinase B (AKT) and Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)/Heme Oxygenase-1 (HO-1) pathways, which reduce oxidative stress, inhibit osteoblast apoptosis, and promote osteoblast differentiation and mineralization. MATERIALS AND METHODS: An in vivo mouse model of iron overload-induced osteoporosis and an in vitro MC3T3-E1 osteoblast model were used. In vitro experiments involved the use of ZGP containing-serum, along with transcriptomic analysis, Western blot, flow cytometry, TUNEL staining, and immunofluorescence, to assess the effects on oxidative stress, mitochondrial function, and apoptosis. In vivo experiments evaluated the effects of ZGP on bone mass, oxidative stress, and apoptosis using Micro-computed tomography (micro-CT), Hematoxylin and eosin staining (H&E), TUNEL staining, and immunohistochemistry. RESULTS: The study found that ZGP containing-serum significantly enhanced the viability of osteoblasts induced by iron overload and reduced apoptosis through the reactive oxygen species (ROS)-mediated Phosphoinositide 3-Kinase (PI3K)/Protein Kinase B (AKT) pathway while mitigating mitochondrial damage. In vivo, micro-computed tomography results showed that ZGP improved bone mass, and decreased ROS and apoptosis, consistent with the in vitro findings. CONCLUSION: ZGP demonstrates significant antioxidant and anti-apoptotic effects in iron overload-induced osteoporosis, primarily through the ROS-mediated PI3K/AKT pathway and by reducing mitochondrial damage. These findings suggest that ZGP may be a promising therapeutic agent for treating osteoporosis associated with iron overload.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First School of Clinical Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, PR China; The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center,…
- Department of Orthopaedics, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, 16 Jichang Road, Baiyun Area, Guangzhou, 510405, PR China.
- Department of Orthopaedics, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, 16 Jichang Road, Baiyun Area, Guangzhou, 510405, PR China. Electronic address: drzsc@sina.com.
Förderung
- Guangdong Provincial Natural Science Foundation
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Lin, Y., He, Q., Chen, B., Li, Z., Chen, C., Deng, W., Li, H., Yang, J., Mai, B., Zhang, Z., Wang, D., Guo, H., Tang, Y., Yuan, K., Mo, G., Xu, L., Li, Y., Wang, H., & Zhang, S. (2025). Zuogui Pills alleviate iron overload-induced osteoporosis by attenuating ROS-mediated osteoblast apoptosis via the PI3K-AKT pathway and mitigating mitochondrial damage. Journal of Ethnopharmacology, 344, 119455. https://doi.org/10.1016/j.jep.2025.119455
Vancouver
Lin Y, He Q, Chen B, Li Z, Chen C, Deng W, et al. Zuogui Pills alleviate iron overload-induced osteoporosis by attenuating ROS-mediated osteoblast apoptosis via the PI3K-AKT pathway and mitigating mitochondrial damage. Journal of Ethnopharmacology. 2025;344:119455. doi:10.1016/j.jep.2025.119455
BibTeX
@article{Lin2025,
author = {Lin, Yuewei and He, Qi and Chen, Baihao and Li, Zuang and Chen, Chuyi and Deng, Wei and Li, Haishan and Yang, Jiamin and Mai, Bin and Zhang, Zhen and Wang, Dongping and Guo, Huizhi and Tang, Yongchao and Yuan, Kai and Mo, Guoye and Xu, Liangliang and Li, Yongxian and Wang, Haibin and Zhang, Shuncong},
title = {Zuogui Pills alleviate iron overload-induced osteoporosis by attenuating ROS-mediated osteoblast apoptosis via the PI3K-AKT pathway and mitigating mitochondrial damage},
journal = {Journal of Ethnopharmacology},
year = {2025},
volume = {344},
pages = {119455},
doi = {10.1016/j.jep.2025.119455}
}
EUVIMED